Ozempic FDA Approval Status (2026) – Approved or Not?
FDA Regulatory Database

Is Ozempic
FDA approved?

DrugStatusIndex.com provides a plain-English status page for Ozempic, including FDA approval status, prescription classification, compounding context, pricing information, and regulatory notes.

FDA approved
FDA status
Medication / drug-name index candidate
Drug category
2026-05-04
Last reviewed
Drug status summary

Ozempic

FDA approved

Ozempic is included as a DrugStatusIndex entry based on the FDA Orange Book Product Name Index and should be reviewed before publishing.

Brand names
Ozempic
Prescription status
Available by prescription or OTC depending on the specific FDA-approved product, labeling, and route.
Compounded status
Commercial FDA-approved product; verify exact product, route, and indication
Confusion level
Medium
FDA Approved Approved for commercial use in the US
Not Approved Not cleared by FDA for use
Investigational Under review or in clinical trials
Rx Only Prescription required — not OTC
FDA approval status

Ozempic approval status and regulatory context

This page is structured for LPagery Pro and uses your CSV fields to create a consistent, scalable drug-status page that matches the current DrugStatusIndex.com home page design.

What DrugStatusIndex currently shows

Ozempic is included as a DrugStatusIndex entry based on the FDA Orange Book Product Name Index and should be reviewed before publishing.

Regulatory note: Users should verify labeling, approved indications, route, dosage form, and current FDA guidance directly through official FDA resources.
FDA status
FDA approved
Drug category
Medication / drug-name index candidate
Prescription status
Available by prescription or OTC depending on the specific FDA-approved product, labeling, and route.
Availability note
Availability depends on prescription eligibility, OTC status, pharmacy supply, insurance coverage, and current market access.

Index review fields

Review status
Needs review
Last checked
2026-05-04
Published
No
Page URL
https://drugstatusindex.com/is-ozempic-fda-approved/
Pricing and access

Ozempic pricing information

Pricing can vary by dose, pharmacy, insurance coverage, manufacturer savings, coupon programs, market availability, and current supply conditions.

Retail estimate
$1,000-$1,400 / month

Estimated cash or retail pricing range when available.

Coupon estimate
$199-$825 with public coupon or savings program

Discount-card or pharmacy coupon estimate when available.

Pricing last checked
May 2026

Pricing data should be rechecked before making financial or treatment decisions.

Pricing summary

Ozempic estimated cash pricing: $1,000-$1,400 / month. Discount/coupon estimate: $199-$825 with public coupon or savings program. Pricing varies by dose, quantity, pharmacy, location, insurance, and current savings programs.

Coverage and savings notes

Manufacturer savings: Novo Nordisk savings card may lower eligible commercial copay to about $25; self-pay programs may apply

Insurance note: Often covered for Type 2 diabetes; prior authorization common; not usually covered solely for weight loss

Sources and verification

Verify Ozempic directly with trusted source material

DrugStatusIndex.com is an informational resource. FDA status, availability, and pricing should be independently verified using official FDA resources, pharmacy data, prescribing information, and licensed healthcare guidance.

FDA / regulatory source
https://www.fda.gov/media/71494/download?attachment=
Pricing source
https://www.goodrx.com/ozempic | https://www.drugs.com/price-guide/ozempic

Preview this drug-status page

Use this button to preview the generated LPagery page for Ozempic and confirm the page output before wider publishing.

Preview Page →
Informational resource only
DrugStatusIndex.com reflects publicly available FDA regulatory data and does not provide medical advice, diagnosis, treatment recommendations, pharmacy recommendations, or legal/regulatory advice. Always consult a licensed healthcare provider before making any medical decision.
Scroll to Top